Literature DB >> 21779476

Context-Specific Growth Hormone Signaling through the Transcription Factor STAT5: Implications for the Etiology of Hepatosteatosis and Hepatocellular Carcinoma.

Kyung Hyun Yoo1, Myunggi Baik, Lothar Hennighausen.   

Abstract

Growth hormone (GH) controls hepatic physiology to a large extent through the transcription factor signal transducers and activators of transcription (STAT) 5. Here, we focus on lessons learned from the physiology and pathophysiology of mice with disrupted Ghr and Stat5 loci. We discuss that hepatosteatosis and hepatocellular carcinoma observed in the absence of STAT5 can be explained in part through an aberrant activation of STAT1 and STAT3, which in themselves promote cell proliferation and survival. We also argue that STAT5 can be a context-specific tumor suppressor as it negatively regulates cell cycle progression. Lastly, we discuss promiscuity between STAT members that permits a given cytokine receptor to activate different STATs and thereby elicit context-dependent biological responses.

Entities:  

Keywords:  STAT5; gene knockout; growth hormone; hepatocellular carcinoma; hepatosteatosis

Year:  2011        PMID: 21779476      PMCID: PMC3111010          DOI: 10.1177/1947601911405046

Source DB:  PubMed          Journal:  Genes Cancer        ISSN: 1947-6019


  37 in total

1.  In vivo targeting of the growth hormone receptor (GHR) Box1 sequence demonstrates that the GHR does not signal exclusively through JAK2.

Authors:  Johanna L Barclay; Linda M Kerr; Leela Arthur; Jennifer E Rowland; Caroline N Nelson; Mayumi Ishikawa; Elisabetta M d'Aniello; Mary White; Peter G Noakes; Michael J Waters
Journal:  Mol Endocrinol       Date:  2009-11-02

2.  Signaling by intrathymic cytokines, not T cell antigen receptors, specifies CD8 lineage choice and promotes the differentiation of cytotoxic-lineage T cells.

Authors:  Jung-Hyun Park; Stanley Adoro; Terry Guinter; Batu Erman; Amala S Alag; Marta Catalfamo; Motoko Y Kimura; Yongzhi Cui; Philip J Lucas; Ronald E Gress; Masato Kubo; Lothar Hennighausen; Lionel Feigenbaum; Alfred Singer
Journal:  Nat Immunol       Date:  2010-01-31       Impact factor: 25.606

3.  SOCS3 in liver regeneration and hepatocarcinoma.

Authors:  Joanne Elliott
Journal:  Mol Interv       Date:  2008-02

4.  Transcription factor Stat5 synergizes with androgen receptor in prostate cancer cells.

Authors:  Shyh-Han Tan; Ayush Dagvadorj; Feng Shen; Lei Gu; Zhiyong Liao; Junaid Abdulghani; Ying Zhang; Edward P Gelmann; Tobias Zellweger; Zoran Culig; Tapio Visakorpi; Lukas Bubendorf; Robert A Kirken; James Karras; Marja T Nevalainen
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

5.  Nonalcoholic fatty liver in patients with Laron syndrome and GH gene deletion - preliminary report.

Authors:  Zvi Laron; Shira Ginsberg; Muriel Webb
Journal:  Growth Horm IGF Res       Date:  2008-05-06       Impact factor: 2.372

6.  Role of STAT5a in regulation of sex-specific gene expression in female but not male mouse liver revealed by microarray analysis.

Authors:  Karl H Clodfelter; Gregory D Miles; Valerie Wauthier; Minita G Holloway; Xiaohua Zhang; Paul Hodor; William J Ray; David J Waxman
Journal:  Physiol Genomics       Date:  2007-05-29       Impact factor: 3.107

7.  Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration.

Authors:  Yongzhi Cui; Atsushi Hosui; Rui Sun; Kezhen Shen; Oksana Gavrilova; Weiping Chen; Margaret C Cam; Bin Gao; Gertraud W Robinson; Lothar Hennighausen
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

8.  Maximal STAT5-induced proliferation and self-renewal at intermediate STAT5 activity levels.

Authors:  Albertus T J Wierenga; Edo Vellenga; Jan Jacob Schuringa
Journal:  Mol Cell Biol       Date:  2008-09-08       Impact factor: 4.272

9.  Liver-specific deletion of the growth hormone receptor reveals essential role of growth hormone signaling in hepatic lipid metabolism.

Authors:  Yong Fan; Ram K Menon; Pinchas Cohen; David Hwang; Thomas Clemens; Douglas J DiGirolamo; John J Kopchick; Derek Le Roith; Massimo Trucco; Mark A Sperling
Journal:  J Biol Chem       Date:  2009-05-21       Impact factor: 5.157

10.  Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-{beta} and STAT3 activation.

Authors:  Atsushi Hosui; Akiko Kimura; Daisuke Yamaji; Bing-mei Zhu; Risu Na; Lothar Hennighausen
Journal:  J Exp Med       Date:  2009-03-30       Impact factor: 14.307

View more
  3 in total

Review 1.  Mapping the growth hormone--Stat5b--IGF-I transcriptional circuit.

Authors:  Peter Rotwein
Journal:  Trends Endocrinol Metab       Date:  2012-02-21       Impact factor: 12.015

Review 2.  Hepatic growth hormone and glucocorticoid receptor signaling in body growth, steatosis and metabolic liver cancer development.

Authors:  Kristina M Mueller; Madeleine Themanns; Katrin Friedbichler; Jan-Wilhelm Kornfeld; Harald Esterbauer; Jan P Tuckermann; Richard Moriggl
Journal:  Mol Cell Endocrinol       Date:  2012-04-30       Impact factor: 4.102

3.  Biochemical characterization of diverse Stat5b-binding enhancers that mediate growth hormone-activated insulin-like growth factor-I gene transcription.

Authors:  Ben Varco-Merth; Kasim Mirza; Damir T Alzhanov; Dennis J Chia; Peter Rotwein
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.